n-3 PUFA Improve Emotion and Cognition during Menopause: A Systematic Review
pdf (Español (España))
html (Español (España))

Keywords

menopause

How to Cite

1.
Azas Y, Demayo S. n-3 PUFA Improve Emotion and Cognition during Menopause: A Systematic Review. RSAEGRE [Internet]. 2026 Jul. 28 [cited 2026 Jul. 29];33(2):62-4. Available from: https://www.revistasaegre.com.ar/index.php/revista/article/view/68

Abstract

Women show an increased risk of cognitive impairment and emotional disorders, such as anxiety and depression, when approaching menopause. Data on risk and protection factors have yielded robust evidence on the effects of lifestyle factors, such as diet, in preserving emotional and cognitive functioning. This review focused on the effects of omega-3 polyunsaturated fatty acids (n-3 PUFA) on anxiety, depression, and cognition during the menopausal transition. This systematic review considered all articles published until 31 December 2021, and the search was performed on two databases, PubMed and Scopus. The fields of interest were “menopause”, “n-3 PUFA” and “emotional and cognitive aspects”. Out of the 361 articles found on PubMed and 283 on Scopus, 17 met inclusion criteria. They encompassed 11 human and 6 animal studies. Most studies reported relieved depressive symptoms in relation to n-3 PUFA intake. While controversial results were found on anxiety and cognition in humans, n-3 PUFA consistently reduced anxiety symptoms and improved cognition in animal studies. Taken together, n-3 PUFA intake shows beneficial effects on emotional and cognitive behaviours during menopause transition. However, further investigations could increase knowledge about the effectiveness of n-3 PUFA on psychological well-being in this delicate period of feminine life.

   
pdf (Español (España))
html (Español (España))

References

Monteleone P, Mascagni G, Giannini A, Genazzani AR, Simoncini T. Symptoms of menopause—global prevalence, physiology and implications. Nat Rev Endocrinol. 2018;14(4):199- 215. doi:10.1038/nrendo.2017.180.

Jett S, Schelbaum E, Jang G, Ghadishah E, Ruiz N, Mosconi L. Ovarian steroid hormones: a long overlooked but critical contributor to brain aging and Alzheimer’s disease. Front Aging Neurosci. 2022;14:948219. doi:10.3389/fnagi.2022.948219.

Mosconi L, Berti V, Dyke JP, Schelbaum E, Jett S, Loughlin L, et al. Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition. Sci Rep. 2021;11(1):10867. doi:10.1038/s41598-021-90084-y

Rettberg JR, Yao J, Brinton RD. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol. 2014;35(1):8-30. doi: 10.1016/j.yfrne.2013.08.001.

Decandia D, Landolfo E, Sacchetti S, Gelfo F, Petrosini L, Cutuli D. n-3 PUFA improve emotion and cognition during menopause: a systematic review. Nutrients. 2022;14(9):1982. doi:10.3390/nu14091982.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71

Esta obra está bajo licencia internacional

licencias

https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es 

Downloads

Download data is not yet available.